<DOC>
	<DOCNO>NCT01318239</DOCNO>
	<brief_summary>The purpose study establish accuracy perfusion MRI parameter availability VEGFR2 signal assay use phosphospecific flow cytometry predict response liver metastasis colorectal cancer treatment antiangiogenic agent .</brief_summary>
	<brief_title>Perfusion Diffusion Magnetic Resonance Imaging , Phosphorylation Circulation Endothelial Cells Determine Anti-anogenic Effect Chemotherapeutic Regimens Colorectal Liver Metastasis Patients</brief_title>
	<detailed_description>The purpose study establish accuracy perfusion MRI parameter availability VEGFR2 signal assay use phosphospecific flow cytometry predict response liver metastasis colorectal cancer treatment antiangiogenic agent . IRB approval obtain enroll 60 na√Øve patient ( 30 patient get antiangiogenic agent ( Avastin ) combine chemotherapy 30 patient get chemotherapy without antiangiogenic agent ) liver metastasis colorectal cancer . MRI blood test ( VEGFR2 signal assay ) undergo three time point patient Avastin chemotherapy ; baseline ( pretreatment ) , 3 day Avastin alone treatment , 3 day Avastin combine chemotherapy ( 10 day initial Avastin alone treatment ) . MRI blood test ( VEGFR2 signal assay ) undergo two time point patient get chemotherapy without antiangiogenic agent ; baseline ( pretreatment ) , 3 day chemotherapy .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Patients single multiple liver metastasis colorectal cancer Patients willing undergo study procedure Patients fully inform study sign informed consent form 60 patient ( 30 patient get antiangiogenic agent ( Avastin ) combine chemotherapy 30 patient get chemotherapy without antiangiogenic agent ) Patients ( men woman ) 20 year age Patients previously enter study Patients receive receive investigational drug 48 hour injection study drug study participation Women pregnant , lactate childbearing potential negative pregnancy test baseline visit Patients eligible contrast medium injection accord product labeling Patients contraindication MRI CT Patients impair renal function ( e.g . acute renal failure ) patient dialysis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>